Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Raúl, Navaridas"'
Autor:
Gisela Altés, Anna Olomí, Aida Perramon-Güell, Sara Hernández, Anna Casanovas, Aurora Pérez, Juan Miguel Díaz-Tocados, José Manuel Valdivielso, Cristina Megino, Raúl Navaridas, Xavier Matias-Guiu, Ophir D. Klein, Joaquim Egea, Xavi Dolcet, Andrée Yeramian, Mario Encinas
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Genes of the Sprouty family (Spry1-4) are feedback inhibitors of receptor tyrosine kinases, especially of Ret and the FGF receptors. As such, they play distinct and overlapping roles in embryo morphogenesis and are considered to be tumor sup
Externí odkaz:
https://doaj.org/article/c35f82b053404988a6db6232e37d7598
Autor:
Raúl Navaridas, Maria Vidal‐Sabanés, Anna Ruiz‐Mitjana, Aida Perramon‐Güell, Cristina Megino‐Luque, David Llobet‐Navas, Xavier Matias‐Guiu, Joaquim Egea, Mario Encinas, Lídia Bardia, Julien Colombelli, Xavier Dolcet
Publikováno v:
Cancer Communications, Vol 43, Iss 5, Pp 620-624 (2023)
Externí odkaz:
https://doaj.org/article/07b55548b70041ffb7bc3d9db626bcb2
Autor:
Raúl Navaridas, Maria Vidal‐Sabanés, Anna Ruiz‐Mitjana, Gisela Altés, Aida Perramon‐Güell, Andree Yeramian, Joaquim Egea, Mario Encinas, Sonia Gatius, Xavier Matias‐Guiu, Xavier Dolcet
Publikováno v:
Advanced Science, Vol 10, Iss 32, Pp n/a-n/a (2023)
Abstract Phosphatase and TENsin homolog (Pten) and p53 are two of the most frequently mutated tumor suppressor genes in endometrial cancer. However, the functional consequences and histopathological manifestation of concomitant p53 and Pten loss of f
Externí odkaz:
https://doaj.org/article/a10e9bdc8afb41bba8c8fa70ed603e4f
Autor:
Isabel C. Lopez‐Mejia, Jordi Pijuan, Raúl Navaridas, Maria Santacana, Sònia Gatius, Ana Velasco, Gerard Castellà, Anaïs Panosa, Elisa Cabiscol, Miquel Pinyol, Laura Coll, Núria Bonifaci, Laura Plata Peña, August Vidal, Alberto Villanueva, Eloi Gari, David Llobet‐Navàs, Lluis Fajas, Xavier Matias‐Guiu, Andrée Yeramian
Publikováno v:
Molecular Oncology, Vol 17, Iss 1, Pp 98-118 (2023)
Uterine serous carcinoma (USC) is an aggressive form of endometrial cancer (EC), characterized by its high propensity for metastases. In fact, while endometrioid endometrial carcinoma (EEC), which accounts for 85% of EC, presents a good prognosis, US
Externí odkaz:
https://doaj.org/article/f663469d36c74406919fb1ffb516ab40
Autor:
Anna Ruiz-Mitjana, Raúl Navaridas, Maria Vidal-Sabanés, Aida Perramon-Güell, Andree Yeramian, Isidre Felip, Núria Eritja, Joaquim Egea, Mario Encinas, Xavier Matias-Guiu, Xavier Dolcet
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-19 (2022)
Abstract The extracellular matrix and the correct establishment of epithelial cell polarity plays a critical role in epithelial cell homeostasis and cell polarity. In addition, loss of tissue structure is a hallmark of carcinogenesis. In this study,
Externí odkaz:
https://doaj.org/article/f38b438a650b4c409f3101a0c6d92387
Autor:
Cristina Megino‐Luque, Pol Sisó, Natalia Mota‐Martorell, Raúl Navaridas, Inés de laRosa, Izaskun Urdanibia, Manel Albertí‐Valls, Maria Santacana, Miquel Pinyol, Núria Bonifaci, Anna Macià, David Llobet‐Navas, Sònia Gatius, Xavier Matias‐Guiu, Núria Eritja
Publikováno v:
Molecular Oncology, Vol 16, Iss 11, Pp 2235-2259 (2022)
AT‐rich interactive domain‐containing protein 1A (ARID1A) loss‐of‐function mutation accompanied by a loss of ARID1A protein expression is frequently observed in endometrial carcinomas. However, the molecular mechanisms linking these genetic c
Externí odkaz:
https://doaj.org/article/88829f0c96d5428fb487eeec1a5e9881
Autor:
Natividad Blasco, Aida Beà, Gisel Barés, Cristina Girón, Raúl Navaridas, Andrea Irazoki, Guillermo López-Lluch, Antonio Zorzano, Xavier Dolcet, Marta Llovera, Daniel Sanchis
Publikováno v:
Redox Biology, Vol 37, Iss , Pp 101736- (2020)
The apoptotic nuclease EndoG is involved in mitochondrial DNA replication. Previous results suggested that, in addition to regulate cardiomyocyte hypertrophy, EndoG could be involved in cell proliferation. Here, by using in vivo and cell culture mode
Externí odkaz:
https://doaj.org/article/3e37a358d10e4c7286657f704b4b30d3
Autor:
null Isabel C. Lopez‐Mejia, null Jordi Pijuan, null Raúl Navaridas, null Maria Santacana, null Sònia Gatius, null Ana Velasco, null Gerard Castellà, null Anaïs Panosa, null Elisa Cabiscol, null Miquel Pinyol, null Laura Coll, null Núria Bonifaci, null Laura Plata Peña, null August Vidal, null Alberto Villanueva, null Eloi Gari, null David Llobet‐Navàs, null Lluis Fajas, null Xavier Matias‐Guiu, null Andrée Yeramian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f022c0b74452dd6eba65d4ddb92e8b86
https://doi.org/10.1002/1878-0261.13346/v2/response1
https://doi.org/10.1002/1878-0261.13346/v2/response1
Autor:
Tània Cemeli, Marta Guasch-Vallés, Marina Ribes-Santolaria, Eva Ibars, Raúl Navaridas, Xavier Dolcet, Neus Pedraza, Neus Colomina, Jordi Torres-Rosell, Francisco Ferrezuelo, Judit Herreros, Eloi Garí
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 15; Pages: 8199
Repositorio Abierto de la UdL
Universitad de Lleida
Repositorio Abierto de la UdL
Universitad de Lleida
Glioblastoma (GBM) is the most common tumor in the central nervous system in adults. This neoplasia shows a high capacity of growth and spreading to the surrounding brain tissue, hindering its complete surgical resection. Therefore, the finding of ne
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Autor:
Oscar Maiques, Xavier Dolcet, Izaskun Urdanibia, R.M. Penín, Sandra García-Mulero, Pol Sisó, Nuria Eritja, Carla Barceló, X. Soria, Rosa M. Martí, Isidre Felip, Anna Macià, Josep M. Piulats, Cristina Megino, Raúl Navaridas, Rebeca Sanz-Pamplona, Xavier Matias-Guiu
Publikováno v:
Journal of Investigative Dermatology. 140:1253-1265
Melanoma is a malignant neoplasia that is highly resistant to chemotherapy and radiotherapy and is associated with poor prognosis in advanced stage. Targeting melanoma that harbors the common BRAFV600E mutation with kinase inhibitors, such as vemuraf